Gene therapy's clinical promise depends on a deceptively simple premise: that a viral vector can reliably navigate the complex interior of a human cell and deliver its genetic payload. A newly identified molecular checkpoint challenges assumptions about how well we understand that journey, and points toward a concrete target for improving the efficiency of one of medicine's most important delivery platforms.
Published in PNAS, the study identifies TBC1D23 as a critical host adaptor protein mediating the transit of recombinant adeno-associated virus (rAAV) particles from endosomes to the trans-Golgi network (TGN), a trafficking route previously undercharacterized in the context of AAV transduction. TBC1D23 appears to function by bridging the established AAV receptor (AAVR) with the retrograde transport machinery, essentially acting as a molecular relay that hands off viral cargo between cellular compartments. Disruption of TBC1D23 function impaired productive transduction, confirming this step as functionally required rather than incidental.
This finding matters well beyond basic cell biology. rAAVs currently serve as the delivery backbone for approved therapies targeting spinal muscular atrophy, hemophilia, and inherited retinal dystrophy, yet dose-limiting immunogenicity and variable transduction efficiency remain persistent challenges. Much of that variability has been attributed to capsid serotype differences or tissue tropism, but intracellular trafficking bottlenecks represent an underexplored contributor. If TBC1D23 activity varies across cell types or individuals, it could help explain why the same vector achieves dramatically different outcomes in different patients. From an engineering perspective, the TBC1D23–AAVR interaction now represents a rational target: modulating this axis could potentially lower the effective dose needed for therapeutic transduction, which directly addresses the immunogenicity problem. This is incremental in the sense that it maps one step in a known pathway, but it is conceptually significant because it reframes intracellular trafficking as a tunable variable in vector design rather than a passive backdrop.